Charles A. Rowland, Jr.
DirectoratViking Therapeutics· In proxies 2023–2025
Charles A. Rowland, Jr. sits on 8 public boards.
Experience
- Viking TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +213%
- Blueprint Medicines CorporationPublic company
- Director? – PresentNo stock prices for these years
- Orchard TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Generation Bio Co.Public company · 8 yr
- Director2018 – 2026 · 8 yrNo stock prices for these years
- Nabriva Therapeutics, AGPublic company · 10 yr
- Director2015 – 2025 · 10 yrNo stock prices for these years
- Psioxus TherapeuticsPublic company · 2 yr
- Director2017 – 2019 · 2 yrNo stock prices for these years
- BIND Therapeutics, Inc.Public company · 2 yr
- Director2014 – 2016 · 2 yrNo stock prices for these years
- Vitae Pharmaceuticals, Inc.Public company · 2 yr
- Director2014 – 2016 · 2 yrNo stock prices for these years
- Idenix Pharmaceuticals, Inc.Public company · 1 yr
- Director2013 – 2014 · 1 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?